Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India

The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe vivax malaria in Gujarat, one of the main con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anupkumar R. Anvikar, Anna Maria van Eijk, Asha Shah, Kamlesh J. Upadhyay, Steven A. Sullivan, Ankita J. Patel, Jaykumar M. Joshi, Suchi Tyagi, Ranvir Singh, Jane M. Carlton, Himanshu Gupta, Samuel C. Wassmer
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2020
Materias:
Acceso en línea:https://doaj.org/article/e7d24da3b2d949c19350cec0f8c913d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e7d24da3b2d949c19350cec0f8c913d2
record_format dspace
spelling oai:doaj.org-article:e7d24da3b2d949c19350cec0f8c913d22021-11-17T14:21:58ZClinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India2150-55942150-560810.1080/21505594.2020.1773107https://doaj.org/article/e7d24da3b2d949c19350cec0f8c913d22020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1773107https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe vivax malaria in Gujarat, one of the main contributors to the vivax malaria burden in the country, have been reported recently and may be the result of a decrease in transmission and immune development. Over a period of one year, we enrolled severe malaria patients admitted at the Civil Hospital in Ahmedabad, the largest city in Gujarat, to investigate the morbidity of severe vivax malaria compared to severe falciparum malaria. Patients were submitted to standard thorough clinical and laboratory investigations and only PCR-confirmed infections were selected for the present study. Severevivax malaria (30 patients) was more frequent than severe falciparum malaria (8 patients) in our setting, and it predominantly affected adults (median age 32 years, interquartile range 22.5 years). This suggests a potential age shift in anti-malarial immunity, likely to result from the recent decrease in transmission across India. The clinical presentation of severe vivax patients was in line with previous reports, with jaundice as the most common complication. Our findings further support the need for epidemiological studies combining clinical characterization of severe vivax malaria and serological evaluation of exposure markers to monitor the impact of elimination programmes.Anupkumar R. AnvikarAnna Maria van EijkAsha ShahKamlesh J. UpadhyaySteven A. SullivanAnkita J. PatelJaykumar M. JoshiSuchi TyagiRanvir SinghJane M. CarltonHimanshu GuptaSamuel C. WassmerTaylor & Francis Grouparticlesevere malariaplasmodium vivaxgujaratindiamalaria eliminationInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 730-738 (2020)
institution DOAJ
collection DOAJ
language EN
topic severe malaria
plasmodium vivax
gujarat
india
malaria elimination
Infectious and parasitic diseases
RC109-216
spellingShingle severe malaria
plasmodium vivax
gujarat
india
malaria elimination
Infectious and parasitic diseases
RC109-216
Anupkumar R. Anvikar
Anna Maria van Eijk
Asha Shah
Kamlesh J. Upadhyay
Steven A. Sullivan
Ankita J. Patel
Jaykumar M. Joshi
Suchi Tyagi
Ranvir Singh
Jane M. Carlton
Himanshu Gupta
Samuel C. Wassmer
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
description The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe vivax malaria in Gujarat, one of the main contributors to the vivax malaria burden in the country, have been reported recently and may be the result of a decrease in transmission and immune development. Over a period of one year, we enrolled severe malaria patients admitted at the Civil Hospital in Ahmedabad, the largest city in Gujarat, to investigate the morbidity of severe vivax malaria compared to severe falciparum malaria. Patients were submitted to standard thorough clinical and laboratory investigations and only PCR-confirmed infections were selected for the present study. Severevivax malaria (30 patients) was more frequent than severe falciparum malaria (8 patients) in our setting, and it predominantly affected adults (median age 32 years, interquartile range 22.5 years). This suggests a potential age shift in anti-malarial immunity, likely to result from the recent decrease in transmission across India. The clinical presentation of severe vivax patients was in line with previous reports, with jaundice as the most common complication. Our findings further support the need for epidemiological studies combining clinical characterization of severe vivax malaria and serological evaluation of exposure markers to monitor the impact of elimination programmes.
format article
author Anupkumar R. Anvikar
Anna Maria van Eijk
Asha Shah
Kamlesh J. Upadhyay
Steven A. Sullivan
Ankita J. Patel
Jaykumar M. Joshi
Suchi Tyagi
Ranvir Singh
Jane M. Carlton
Himanshu Gupta
Samuel C. Wassmer
author_facet Anupkumar R. Anvikar
Anna Maria van Eijk
Asha Shah
Kamlesh J. Upadhyay
Steven A. Sullivan
Ankita J. Patel
Jaykumar M. Joshi
Suchi Tyagi
Ranvir Singh
Jane M. Carlton
Himanshu Gupta
Samuel C. Wassmer
author_sort Anupkumar R. Anvikar
title Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
title_short Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
title_full Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
title_fullStr Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
title_full_unstemmed Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
title_sort clinical and epidemiological characterization of severe plasmodium vivax malaria in gujarat, india
publisher Taylor & Francis Group
publishDate 2020
url https://doaj.org/article/e7d24da3b2d949c19350cec0f8c913d2
work_keys_str_mv AT anupkumarranvikar clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT annamariavaneijk clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT ashashah clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT kamleshjupadhyay clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT stevenasullivan clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT ankitajpatel clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT jaykumarmjoshi clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT suchityagi clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT ranvirsingh clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT janemcarlton clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT himanshugupta clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
AT samuelcwassmer clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia
_version_ 1718425517388988416